Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
1.020
-0.030 (-2.86%)
At close: Nov 21, 2024, 4:00 PM
1.021
+0.001 (0.11%)
After-hours: Nov 21, 2024, 5:14 PM EST
Clearside Biomedical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -31.88 | -32.49 | -32.95 | 0.38 | -18.21 | -30.77 | |
Depreciation & Amortization | 0.17 | 0.07 | 0.15 | 0.18 | 0.18 | 0.21 | |
Other Amortization | - | - | - | - | 0.13 | 0.07 | |
Loss (Gain) From Sale of Assets | - | - | 0.03 | - | - | 0.06 | |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.12 | |
Stock-Based Compensation | 4.37 | 4.2 | 4.88 | 5.05 | 3.6 | 4.61 | |
Other Operating Activities | 8.41 | 9.36 | 3.28 | -1 | 0.06 | 0.16 | |
Change in Accounts Payable | -0.48 | 0.61 | 0.69 | 0.68 | -0.63 | -5.58 | |
Change in Unearned Revenue | - | -0.13 | 0.21 | -5 | - | 5 | |
Change in Other Net Operating Assets | 0.46 | 0.24 | 10.34 | -11.02 | 1.75 | -0.72 | |
Operating Cash Flow | -18.95 | -18.14 | -13.37 | -10.73 | -13.12 | -27.07 | |
Capital Expenditures | -0.65 | -1.78 | -0.25 | - | -0.06 | -0.03 | |
Investment in Securities | -9.41 | - | - | - | - | 32.95 | |
Investing Cash Flow | -10.07 | -1.78 | -0.25 | - | -0.06 | 32.93 | |
Long-Term Debt Issued | - | - | - | - | 0.99 | - | |
Long-Term Debt Repaid | - | - | - | - | -5.34 | -5 | |
Net Debt Issued (Repaid) | - | - | - | - | -4.35 | -5 | |
Issuance of Common Stock | 15.1 | 1.76 | 0.7 | 23.78 | 12.22 | 13.7 | |
Other Financing Activities | -1 | -1.35 | 30.64 | - | - | - | |
Financing Cash Flow | 14.1 | 0.41 | 31.33 | 23.78 | 7.87 | 8.7 | |
Net Cash Flow | -14.91 | -19.5 | 17.72 | 13.05 | -5.31 | 14.55 | |
Free Cash Flow | -19.6 | -19.91 | -13.61 | -10.73 | -13.18 | -27.09 | |
Free Cash Flow Margin | -254.47% | -242.06% | -1025.70% | -36.29% | -166.90% | -1246.80% | |
Free Cash Flow Per Share | -0.28 | -0.32 | -0.23 | -0.18 | -0.28 | -0.71 | |
Cash Interest Paid | - | - | - | - | 0.52 | 0.84 | |
Levered Free Cash Flow | -17.37 | -17.93 | -4.49 | -10.35 | -6.4 | -15.99 | |
Unlevered Free Cash Flow | -11.45 | -12.08 | -2.4 | -10.35 | -6.32 | -15.41 | |
Change in Net Working Capital | -0.24 | -0.96 | -11.74 | 15.2 | -1.16 | 1.27 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.